24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Clal Biotechnology Industries
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:14
Johny Srouji weighs leaving Apple, raising stakes for the Israeli executive who built its silicon program
19:40
Greece approves $750M rocket deal with Elbit amid negotiations for $3.5B Israeli air-defense systems
19:09
Intel VP: “We’re just not going to accept subpar products”
10:39
Intel’s decision to keep NEX signals stability for Israel’s 350 networking staff
More stories
Buzz
Most popular
Daily
Weekly
1
“Other countries have air-defense systems, but Israel’s are better”: Arrow 3 lands in Germany as Israel pursues new mega deals
2
Unit 8200 veterans raise $22 million Series A for real-time impersonation defense
3
Cybereason founders' 7AI raises record $130 million Series A in breakneck rise
4
Check Point raises $1.75 billion, potentially eyeing AI expansion
5
Nice puts Actimize up for sale at a $1.5-2 billion price tag
More news
Clal Biotechnology Industries
5 stories about Clal Biotechnology Industries
CBI plans to issue new SPAC to merge with Israeli life science company
18.03.21
|
Hezi Sternlicht
The Israeli biotech giant plans to raise $100 million on Nasdaq to acquire a company that’s involved in advanced healthcare solutions
Elicio Therapeutics enters Covid-19 vaccine race, reports success in pre-clinical trials
19.08.20
|
Sophie Shulman
Boston company partially owned by Clal Biotechnology Industries plans to advance to clinical trials in Q4
Sight Diagnostics raises $71 million amidst Covid-19 demand for blood count devices
26.07.20
|
CTech
Israeli startup develops machine vision-based technology for blood test analysis and infectious disease diagnosis
Cost-Cutting at CureTech Following Cancellation of Acquisition Deal with Insight
05.07.18
|
CTech
The deal was announced in March, but intended buyer InSight backed out
Three Portfolio Companies of Len Blavatnik's Clal Biotechnology Raise Cash in One Week
04.07.18
|
CTech
Clal Biotechnology Industries is an Israel-based life sciences investment company